Eli Lilly marketed the first human insulin, Humulin, in 1982. Humulin was the first medication produced using modern genetic engineering techniques in which actual human DNA is inserted into a host cell (E. coli). The host cells are then allowed to grow and reproduce normally, and due to the inserted human DNA through plasmids, they produce a synthetic version of human insulin.